valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobichon, H; Chatron-Colliet, A; Duca, L; Kurdykowski, S; Lalun, N; Lorenzato, M; Ploton, D; Rusciani, A; Terryn, C | 1 |
| Darvas, Z; Falus, A; Pocza, P; Süli-Vargha, H | 1 |
2 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and Malignant Melanoma
| Article | Year |
|---|---|
The elastin peptide (VGVAPG)3 induces the 3D reorganisation of PML-NBs and SC35 speckles architecture, and accelerates proliferation of fibroblasts and melanoma cells.
Topics: Adult; Cell Line; Cell Nucleus; Cell Proliferation; Elastin; Fibroblasts; Humans; Imaging, Three-Dimensional; Melanoma; Oligopeptides; RNA Splicing; Structure-Activity Relationship | 2015 |
Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Chemokine CXCL12; Chemotaxis; Disease Progression; Elastin; Flow Cytometry; Galectin 3; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Melanoma; Neoplasm Invasiveness; Neovascularization, Pathologic; Oligopeptides; Polymerase Chain Reaction; Receptors, CXCR4; Skin Neoplasms; Tropoelastin; Vascular Endothelial Growth Factor C | 2008 |